NEWSROOM

PRISM MarketView

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis

Dec 19, 2024

Cardiol Therapeutics President and CEO, David Elsley NEW YORK, December 18, 2024 - PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics President and CEO, David Elsley, who discusses the company’s lead oral drug, CardiolRx™, which is entering a late-stage Phase III clinical trial, MAVERIC, for patients with recurrent pericarditis who are at high risk for recurrence. Cardiol Therapeutics is a clinical-stage life sciences company...

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Nov 13, 2024

Company advancing late-stage clinical programs with novel therapies that target underserved heart diseases NEW YORK, November 13, 2024 - PRISM MediaWire - PRISM MarketView, a leading provider of market insights and company news, proudly announces that Cardiol Therapeutics Inc. (NASDAQ: CRDL, TSX: CRDL) has been added to the PRISM Emerging Biotech Index, which spotlights companies leading innovation and creating market impact within the biotech sector. Cardiol’s focus on anti-inflammatory and...

PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor

PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor

Oct 21, 2024

NEW YORK, October 21, 2024 – PRISM MediaWire - PRISM MarketView is proud to announce its role as the official media sponsor for the upcoming ThinkEquity Conference, a premier event bringing together investors, innovators, and industry leaders. The conference will be held at the Mandarin Oriental New York on Oct. 30, offering an exceptional platform for companies and investors to connect, collaborate and explore emerging opportunities. The ThinkEquity Conference is hosted by ThinkEquity, a...

In Light of World Mental Health Day, PRISM Highlights Mental Health Index Companies Making a Difference

In Light of World Mental Health Day, PRISM Highlights Mental Health Index Companies Making a Difference

Oct 10, 2024

New York, New York, October 10, 2024 - PRISM MediaWire - PRISM MediaWire - Mental health has not always been a topic to discuss as easily as other health related topics due to the stigma surrounding it. Those who have identified having a mental health condition typically do not seek the proper help or treatment for fear of judgement or admission to being unstable. The reality of it is that whether or not you have a condition, we all need to do things to ensure we have good mental health in the...

PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month

PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month

Sep 25, 2024

NEW YORK, September 25, 2024 - PRISM MediaWire - PRISM MarketView presents an exclusive Q&A with Dr. Michael Chancellor, Co-founder and Chief Medical Officer of Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO). In this interview, Dr. Chancellor provides insights into the company's latest advancements in urological treatments, particularly in recognition of Urology Awareness Month, and discusses the significant progress made in the development of therapies for hemorrhagic cystitis (HC)....

Aclarion Added to PRISM Emerging Medical Devices Index

Aclarion Added to PRISM Emerging Medical Devices Index

Sep 6, 2024

Company's industry-first technology addresses chronic low back pain Aclarion secured its first commercial agreement with Michigan's Sheridan Community Hospital PRISM Emerging Medical Devices Index features companies at forefront of innovation and market disruption in medtech NEW YORK, September 06, 2024 – PRISM MarketView, a leading provider of market insights and company news, is excited to announce that Aclarion, Inc. (NASDAQ: ACON) has been added to the PRISM Emerging Medical Devices Index,...

PRISM MarketView Launches AI Infrastructure and Datacenter Index

PRISM MarketView Launches AI Infrastructure and Datacenter Index

Aug 1, 2024

New Index Showcases Companies Positioned to Fuel the Booming AI Market NEW YORK, August 01, 2024-- PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging AI Infrastructure and Datacenter Index in response to significant global growth and interest in AI technology. The new PRISM index tracks emerging companies supplying AI-related infrastructure and the datacenters that store this technology. The global AI market...

PRISM MarketView Examines Airline Industry Policies, Financial Reports and Consumer Trends

PRISM MarketView Examines Airline Industry Policies, Financial Reports and Consumer Trends

Jul 30, 2024

NEW YORK, NY July 30, 2024 - PRISM MarketView, a leader within the financial markets and news community, announces the release of an article highlighting the traveling consumer as airlines began to announce financial results. Company reports have echoed larger themes related to higher fuel costs, robust travel demand and lower fare discounting driven by competition from low-cost carriers. American Airlines faced a significant decline in profits due in part to an operational decision to make...

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study

Jun 3, 2024

New York, June 3, 2024—Oncocyte’s (Nasdaq: OCX) VitaGraft Kidney™ diagnostic test for transplant monitoring has shown promising results in a Phase 2 clinical trial, published in the prestigious New England Journal of Medicine. The trial evaluated the test's effectiveness in monitoring graft health in patients with antibody-mediated rejection (AMR), a leading cause of kidney transplant failure. The study's positive outcomes highlight new clinical uses for VitaGraft Kidney, including therapeutic...

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology

May 23, 2024

LAS VEGAS, NEVADA, May 23, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a leading innovator and enabler of AI infrastructure technology, announces its engagement with Wired4Tech, a renowned AI infrastructure consulting firm. As part of its existing technology services agreement with Wired4Tech, Avant Technologies has engaged Wired4Tech to conduct comprehensive performance benchmarking of a next-generation AI cloud server that Avant is evaluating for future use in...

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

May 23, 2024

- Record net sales for fiscal year 2024 increased 31% - - Net income increased 127% year over year – -Provides Q1 and Full Fiscal Year 2025 Revenue Guidance – -Backlog Increased to Year-over-Year Record High – -Conference Call Thursday, May 23, 2024 at 9:30am EST – MILTON, NY, May 23, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its fourth quarter and fiscal year 2024, ended February 29,...

Formation Minerals, Inc. Announces Opportunistic Divestiture of Assets

Formation Minerals, Inc. Announces Opportunistic Divestiture of Assets

May 22, 2024

Divestiture includes five non-core or under-performing properties JACKSBORO, TEXAS, May 22, 2024 – Formation Minerals, Inc. (OTCQB: FOMI) (“Formation” or the “Company”), a growing oil and gas company with a focus on the acquisition and management of oil and gas minerals and royalties, today announced that, on May 21, 2024, it sold five non-core lower performing assets for $140,000 to a private buyer. “This is a great example of responsible portfolio management and the solid execution of our...

SS Innovations’ SSi Mantra Surgical Robotic System Used to Perform 100 Cardiac Surgeries, Signaling Market Expansion

SS Innovations’ SSi Mantra Surgical Robotic System Used to Perform 100 Cardiac Surgeries, Signaling Market Expansion

May 21, 2024

The SSi Mantra has surpassed the 100 surgery milestone for robotic cardiac surgery SS Innovations maintains the world's only comprehensive robotic cardiac surgery program SSi Mantra used in more than 1000 procedures globally Company anticipates FDA approval in early 2025 FORT LAUDERDALE, FL, May 21, 2024 - SS Innovations International, Inc. (the "Company" or "SS Innovations") (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery...

Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b

Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b

May 21, 2024

Share: Company to initiate Phase 2b clinical trial in lead asset, LP-10 in 2H 2024 Pittsburgh, PA, May 21, 2024 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company, announced today the receipt of U.S. Food & Drug Administration (“FDA”) Type-C meeting guidance regarding the LP-10 (liposomal tacrolimus) clinical program. Lipella expects to initiate a Phase 2b clinical trial evaluating LP-10 as a treatment for hemorrhagic...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

May 21, 2024

Meeting Will be Held at The Hilton Hotel, San Francisco, CA SAN FRANCISCO, CA, May 21, 2024—American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that its Annual Meeting of Shareholders will be held on Tuesday, June 25, 2024, at 9:00 a.m. PT. The Annual Meeting will be an in-person meeting. For those who wish to attend, the...

FREEDOM HOLDINGS CORPORATE UPDATE: MANAGEMENT ANNOUNCES A CHANGE OF AUDIT FIRMS HAS BEEN COMPLETED

FREEDOM HOLDINGS CORPORATE UPDATE: MANAGEMENT ANNOUNCES A CHANGE OF AUDIT FIRMS HAS BEEN COMPLETED

May 21, 2024

Chatsworth, CA, May 21, 2024 - Freedom Holdings, Inc. aka Freedom Acquisition Corp (OTC: FHLD) ("FHLD" or the "Company") is pleased to announce that the Company has engaged Olayinka Oyebola & CO Chartered Accountants to complete the requirement of having the financial statements audited by a member of the Public Company Accounting Oversight Board. (PCAOB). On May 3, 2024 the Securities Exchange Commission (Commission) announced an administrative action against BF Borger CPA PC and that...

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

Sono-Tek Announces Year-End FY 2024 Earnings Conference Call

May 20, 2024

Conference Call on Thursday, May 23, 2024, at 9:30 am ET MILTON, NY, May 20, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that the Company will hold a conference call to discuss its year-end fiscal year 2024 financial results, ended February 29, 2024, on Thursday, May 23, 2024 at 9:30 am ET. The year-end FY 2024 financial results press release will be issued before the market opens on May 23, 2024. Conference...

Digital Utilities Ventures Completes Feed Earth Now Merger – Accelerates Growth of Regenerative Agriculture Movement

Digital Utilities Ventures Completes Feed Earth Now Merger – Accelerates Growth of Regenerative Agriculture Movement

May 16, 2024

Mankato, Minnesota, May 16, 2024 - PRISM MediaWire - Digital Utilities Ventures, Inc. (OTC: DUTV) is pleased to announce the successful acquisition of Feed Earth Now, LLC. The consummation of this transaction is a significant step forward in DUTV's mission to leverage innovative, organic products to address global fertilizer shortages through the advancement of regenerative agriculture principles. Mark K. Gaalswyk, the enterprising DUTV CEO behind...

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform

May 16, 2024

LAS VEGAS, NEVADA, May 16, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence (AI) technology company specializing in the development of advanced AI and data center infrastructure solutions, today announced an ambitious plan to develop a cutting-edge, proprietary AI software platform to power its next-generation data centers. This advanced platform will leverage machine learning algorithms to analyze data, predict resource needs, and...

Blackboxstocks Files Form S-4 for Evtec Acquisition

Blackboxstocks Files Form S-4 for Evtec Acquisition

May 16, 2024

Reports First Quarter Financial Results for Fintech Operations Dallas, TX, May 16, 2024 – Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, announced that it filed its Form S-4 on May 13, 2024, for its acquisition of Evtec Aluminium Ltd. and today reported its financial results for the first quarter ended March 31, 2024. The filing of the...

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

May 15, 2024

Conference Call on Wednesday, May 15, 2024, at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, CA, May 15, 2024 - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today reported financial results for the quarter ended March 31, 2024. Recent Highlights Announced global commercialization partnership with Bio-Rad Laboratories, Inc. On track to ship research use only (RUO) GraftAssureTM transplant monitoring test kits to initial customers in Asia, the U.S., and the EU in 2Q 2024. IVD...

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

May 15, 2024

Achieved a 1,407% revenue increase to $1.47 million in Q1 2024. Increased gross margin to 19% in Q1 2024, up from -3% last year. Secured $8 million in recurring revenue plus $1.1 million in rotational retailer commitments. BEND, Ore., May 15, 2024 - PRISM MediaWire - BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced its recent accomplishments and financial results for the first quarter ended March...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

American Shared Hospital Services Reports First Quarter 2024 Financial Results

May 14, 2024

- Reports Record Backlog of $210 million more than doubling following the acquisition of Rhode Island Radiation Therapy Cancer Centers in May 2024 - - Remains on track with opening new Puebla, Mexico center - -Conference Call Today, May 14th at 4:30 pm ET - SAN FRANCISCO, CA, May 14, 2024—American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems...

SKYX Reports Record First Quarter Sales of $19.0 Million Compared to $18.6 Million for First Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products

May 14, 2024

MIAMI, FL, May 14, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies") (the “Company” or “SKYX”), a highly disruptive platform technology company with over 90 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today reported its financial and operational results for the first quarter ended March 31, 2024. First Quarter 2024 and Recent Subsequent Achievements Generated...

BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million

BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million

May 14, 2024

Company Achieves Record-Breaking First Quarter Results for 2024, Marking the Launch of BioStem 2.0 Company Reports First Quarter EBITDA of $4.9 Million Project Continued Growth from Sales of AmnioWrap2 ® Financial Results Conference Call and Webcast on Tuesday, May 14, 2024, at 4:30 pm EDT POMPANO BEACH, FLORIDA, May 14, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived...

Wanderport Corporation Introduces AI-enabled Private Credit Financing Services for International Clients

Wanderport Corporation Introduces AI-enabled Private Credit Financing Services for International Clients

May 14, 2024

SANTA MONICA, CA, May 14, 2024 – Wanderport Corporation (OTC: WDRP), a holding company, with a focus on energy, clean tech, health tech, and applied AI today introduces its Private Credit Financing Services for global clients.Wanderport's new offering is designed to support a diverse array of industries worldwide, leveraging an extensive network of brokers and direct funders to empower global enterprises with tailored financial solutions.The Company's financing services utilize advanced...

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

BranchOut Food Secures Large Scale Production Facility in Peru Capable of $40M in Production Capacity; Estimated 40-50% Gross Margins

May 14, 2024

Build out to begin immediately, with production expected to commence in the third quarter BEND, Ore., May 14, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that it has signed a long term lease for a 50,000 square foot production facility in Peru. Under the terms of the agreement, BranchOut Food has the first right to purchase the facility at a fixed price at any point during the...

Premier Graphene, Inc., formerly Premier Biomedical Inc. (OTC: BIEI), announces major news in Mexico with our friends at HGI Industrial Technologies S.A de P.I and an advancement in its Graphene Enhanced Concrete

Premier Graphene, Inc., formerly Premier Biomedical Inc. (OTC: BIEI), announces major news in Mexico with our friends at HGI Industrial Technologies S.A de P.I and an advancement in its Graphene Enhanced Concrete

May 13, 2024

HGI Industrial Technologies, a company with a strategic agreement with Premier Graphene Inc., has secured one of only three commercial permits for industrial hemp cultivation in Mexico. Test results are outstanding - revealing the material to be stronger, lighter, and faster to process, leading to the production of a superior end product. This marks a significant step in bringing disruptive technology to the construction industry Imperial Valley, CA, May 13, 2024 - PRISM MediaWire - Premier...

Verde Bio and SensaSure Technologies Complete Merger to Create Premier Mineral Acquisitions Company

Verde Bio and SensaSure Technologies Complete Merger to Create Premier Mineral Acquisitions Company

May 13, 2024

The combined company will focus on the acquisition and management of oil and gas of minerals and royalties Combined company renamed Formation Minerals, Inc. and will be led by Mr. Scott Cox as President and Chief Executive Officer Transaction expected to deliver sustainable, long term value to stockholders JACKSBORO, TX, May 13, 2024– SensaSure Technologies, Inc. (OTCQB: SSTC) (“SensaSure”) and Verde Bio Holdings, Inc. (OTC: VBHI) ("Verde" or the "Company"), a growing oil and gas company...

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

Oncocyte to Announce First Quarter 2024 Financial Results

May 13, 2024

Conference Call and Webcast on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, CA, May 13, 2024 - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close. The company will host a conference call and webcast on Wednesday, May 15, 2024, at 4:30 p.m. Eastern Time to discuss its financial results and highlights. Interested parties...